Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 11—November 2020
Dispatch

Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections, France, 2007–2019

Céline Plainvert, Constantin Hays1, Gérald Touak, Caroline Joubrel-Guyot2, Nicolas Dmytruk, Amandine Frigo, Claire Poyart, and Asmaa TaziComments to Author 
Author affiliations: Assistance Publique–Hôpitaux de Paris Centre Université de Paris, Paris, France (C. Plainvert, C. Hays, C. Joubrel-Guyot, N. Dmytruk, A. Frigo, C. Poyart, A. Tazi); Institut Cochin, Paris (C. Plainvert, G. Touak, C. Poyart, A. Tazi); FHU Prema, Paris (C. Plainvert, C. Poyart, A. Tazi); Université de Paris, Paris (C. Hays, C. Joubrel-Guyot, C. Poyart, A. Tazi)

Main Article

Figure 2

Increasing prevalence of MDR CC17 GBS among neonatal invasive isolates, France, 2007–2019. The annual proportion of infections caused by MDR CC17 GBS, such as those harboring the determinants tet(O), erm(B), and aphA-3, during EOD (blue line), LOD (red line) and overall (black line) are represented. Results are expressed as percentage of total GBS isolates per syndrome and per year. Error bars indicate 95% CIs. Evolutionary trends were analyzed using 2-tailed nonparametric Spearman correlation. CC, clonal complex; EOD, early-onset disease; GBS, group B Streptococcus; LOD, late-onset disease; MDR, multidrug-resistant.

Figure 2. Increasing prevalence of MDR CC17 GBS among neonatal invasive isolates, France, 2007–2019. The annual proportion of infections caused by MDR CC17 GBS, such as those harboring the determinants tet(O), erm(B), and aphA-3, during EOD (blue line), LOD (red line) and overall (black line) are represented. Results are expressed as percentage of total GBS isolates per syndrome and per year. Error bars indicate 95% CIs. Evolutionary trends were analyzed using 2-tailed nonparametric Spearman correlation. CC, clonal complex; EOD, early-onset disease; GBS, group B Streptococcus; LOD, late-onset disease; MDR, multidrug-resistant.

Main Article

1Current affiliation: APHP-Nord (St. Louis) Université de Paris, Paris, France.

2Current affiliation: Le Raincy Hospital, Montfermeil, France.

Page created: August 13, 2020
Page updated: October 19, 2020
Page reviewed: October 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external